Low-CSD melanomas have a moderate mutational burden and are associated with BRAFV600E mutations while high-CSD melanomas have a higher mutational burden and are associated with NRAS, NF1, and BRAFnonV600E mutations [9]. The gene discussed is NRAS; the disease is melanoma.